Not Yet RecruitingNot Applicable

Investigation of Allergen Sensitization in Newborn Babies Diagnosed With Necrotizing Enterocolitis.

130 participantsStarted 2026-04-01

Plain-language summary

To evaluate the frequency of allergy between 12 and 24 months of age in infants who were treated in the neonatal clinic and had NEC. To investigate the relationship between NEC development and the development of allergy in the later period.

Who can participate

Age range12 Months – 24 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Infants born in our hospital and diagnosed with NEC during the study period.
✓. Age-matched control infants born in our hospital during the same period but without NEC diagnosis.
✓. Written and verbal informed consent obtained from at least one parent.

Exclusion criteria

✕. Infants whose parents did not provide written or verbal consent.
✕. Infants with major congenital anomalies.
✕. Infants with chromosomal disorders.
✕. Infants with gastrointestinal malformations (e.g., duodenal atresia, gastroschisis, omphalocele).
✕. Infants diagnosed with immunodeficiency. -

What they're measuring

The effect of necrotizing enterocolitis development in premature infants on response to allergens.

Timeframe: Through study completion, an average of 1 year

Trial details

NCT IDNCT07562009

SponsorSaglik Bilimleri Universitesi

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-10-01

View on ClinicalTrials.gov More Necrotizing Enterocolitis trials